Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Advancements in technology are transforming how men approach nutrition and overall well-being. With tools like continu ...

Dr. Medha N. Munshi, geriatrician and founder of Joslin's Geriatric Diabetes Program leads research on improving care for ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...